Pharmacokinetic Analysis of Capsaicin After Topical Administration of a High-concentration Capsaicin Patch to Patients With Peripheral Neuropathic Pain Publication Pharmacokinetic Analysis of Capsaicin After Topical Administration of a High-concentration Capsaicin Patch to Patients With Peripheral Neuropathic Pain Capsaicin, a pungent compound in chili peppers, is a highly selective agonist for the transient…CertaraAugust 1, 2009
The Conduct of In Vitro Studies to Address Time-dependent Inhibition of Drug-metabolizing Enzymes: A Perspective of the Pharmaceutical Research and Manufacturers of America (PhRMA) Publication The Conduct of In Vitro Studies to Address Time-dependent Inhibition of Drug-metabolizing Enzymes: A Perspective of the Pharmaceutical Research and Manufacturers of America (PhRMA) Time-dependent inhibition (TDI) of cytochrome P450 (P450) enzymes caused by new molecular entities (NMEs) is…CertaraJuly 1, 2009
In Vitro and In Vivo Induction of Cytochrome p450: A Survey of the Current Practices and Recommendations: A Pharmaceutical Research and Manufacturers of America Perspective Publication In Vitro and In Vivo Induction of Cytochrome p450: A Survey of the Current Practices and Recommendations: A Pharmaceutical Research and Manufacturers of America Perspective Cytochrome P450 (P450) induction is one of the factors that can affect the pharmacokinetics of a drug…CertaraJuly 1, 2009
The Clinical Utility Index as a Practical Multiattribute Approach to Drug Development Decisions Publication The Clinical Utility Index as a Practical Multiattribute Approach to Drug Development Decisions We identify some innovative approaches to predicting overall patient benefit from investigational drugs to support…CertaraJuly 1, 2009
Assessing the Efficiency of Mixed Effects Modeling in Quantifying Metabolism-based Drug-drug Interactions: Using In Vitro Data as an Aid to Assess Study Power Publication Assessing the Efficiency of Mixed Effects Modeling in Quantifying Metabolism-based Drug-drug Interactions: Using In Vitro Data as an Aid to Assess Study Power The clinical assessment of metabolic drug-drug interactions (mDDI) may involve population-based pharmacokinetic (POPPK) assessment as…CertaraJuly 1, 2009
Physiologically-based Pharmacokinetics (PBPK) Publication Physiologically-based Pharmacokinetics (PBPK) Allometric scaling is widely used to predict human pharmacokinetic parameters from preclinical species, and many…CertaraJune 1, 2009
In Vitro and In Silico Identification and Characterization of Thiabendazole as a Mechanism-based Inhibitor of CYP1A2 and Simulation of Possible Pharmacokinetic Drug-drug Interactions Publication In Vitro and In Silico Identification and Characterization of Thiabendazole as a Mechanism-based Inhibitor of CYP1A2 and Simulation of Possible Pharmacokinetic Drug-drug Interactions Thiabendazole (TBZ) and its major metabolite 5-hydroxythiabendazole (5OH-TBZ) were screened for potential time-dependent inhibition (TDI) against CYP1A2.…CertaraJune 1, 2009
Population-based Mechanistic Prediction of Oral Drug Absorption Publication Population-based Mechanistic Prediction of Oral Drug Absorption The bioavailability of drugs from oral formulations is influenced by many physiological factors including gastrointestinal…CertaraJune 1, 2009
Towards a Quantitative Framework for the Prediction of DDIs Arising from Cytochrome P450 Induction Publication Towards a Quantitative Framework for the Prediction of DDIs Arising from Cytochrome P450 Induction Although CYP induction is not generally considered to be as clinically relevant as CYP inhibition,…CertaraMay 1, 2009
In Vitro and In Vivo Glucuronidation of Midazolam in Humans Publication In Vitro and In Vivo Glucuronidation of Midazolam in Humans Midazolam (MDZ) is a benzodiazepine used as a CYP3A4 probe in clinical and in vitro studies. A…CertaraApril 1, 2009